T1 CRC protocol 

With the start of the screening on colorectal cancer (CRC) in the Netherlands, it was expected that within a few years 8-40% of all detected colorectal cancers would be early cancers (T1 tumours). This development did necessitate a better understanding of the prognosis, patient selection, treatment options and follow up of this specific group of patients.


The T1 CRC working group developed an evidence-based guideline.


You can access the guideline via the ‘richtlijndatabase‘.


On the 13th of February, 2024, we organised a webinar about the main changes in the care fore patients with a T1 tumor. 


On the 10th of June 2025 we organised a case based webinar about the main changes in the guidelines section 5.1 / 5.2: the treatment of T1 and T2 tumours.  


 


You can watch the last webinar again via the link below!

We use cookies to ensure that we give you the best experience on our website.